elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Genome editing
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Genome editing
RIS
0.002
(Research Intensity Score)
Papers
228
Top papers
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease
2025 · 346 citations
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 · 196 citations
Mitochondrial metabolism and cancer therapeutic innovation
2025 · 177 citations
Enhancing nitrogen use efficiency in agriculture by integrating agronomic practices and genetic advances
2025 · 119 citations
Antioxidant Defense Systems in Plants: Mechanisms, Regulation, and Biotechnological Strategies for Enhanced Oxidative Stress Tolerance
2025 · 76 citations
Newest papers
Label-Free MicroRNA Diagnostics: From CRISPR Nucleases to Nanomaterial-Enhanced Transducers
2026 · 5 citations
Engineering delivery platforms for CRISPR-Cas and their applications in healthcare, agriculture and beyond
2026 · 5 citations
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease
2025 · 346 citations
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 · 196 citations
Mitochondrial metabolism and cancer therapeutic innovation
2025 · 177 citations
A sample from the 100 top papers behind Genome editing.
Create a free account to browse them all →
Genome editing's history
Research intensity over time
Explore Genome editing's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Genome editing's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link